PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
09-May-2024 PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting PureTech Health plc
09-May-2024 Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2024 Nxera Pharma
09-May-2024 First Glasgow Tech Week ‘demonstrates passionate, progressive thirst for innovation,’ says InnoScot Health InnoScot Health
09-May-2024 International Nurses Day offers ‘vital theme for impactful modern NHS’, says InnoScot Health InnoScot Health
09-May-2024 The Future of Home Healthcare: Innovations and Opportunities Markets and Markets
09-May-2024 Brits have an unhealthier lifestyle now than at the peak of Covid, warns expert London Medical Laboratory
09-May-2024 New Report Reveals The Extent of Life Science Sector's Perfect Storm Medicines Discovery Catapult (MDC)
09-May-2024 Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia MedinCell
09-May-2024 Gilead Sciences Appoints Peter Wickersham to Vice-President and General Manager in the UK and Ireland Gilead Sciences
09-May-2024 Pharma and Regulatory Giants Tackle AI Trust and Legislative Challenges at Largest Ever Pistoia Alliance Annual Conference The Pistoia Alliance
09-May-2024 Liverpool Women's NHS Foundation Trust Enhances Patient Engagement with Netcall's Patient Hub Liverpool Women's NHS Foundation Trust
09-May-2024 HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee HUTCHMED
09-May-2024 GenesisCare specialist cancer care centre launches dense breast screening service GenesisCare
08-May-2024 Dr. Tim Garnett, Former Chief Medical Officer of Eli Lilly, Joins Lindus Health's Advisory Board Lindus Health
07-May-2024 Atopia Therapeutics, Formerly HpVac, Announces Appointment of Dr. Gregoire Chevalier as CEO and Business Update Atopia Therapeutics
03-May-2024 Cambridge Cognition spin-out Monument Therapeutics accesses £1.5m for schizophrenia clinical development Cambridge Cognition Holdings plc
03-May-2024 Elekta further strengthens its Elekta ONE software suite with acquisition of Philips treatment planning patent portfolio Elekta
02-May-2024 Lindus Health and University of Oxford Publish Study Citing Key Strategies to Foster Diversity in Clinical Trial Participation Site location, community reflective advertising, translation of study materials and social media outreach among the top methods Lindus Health
02-May-2024 Huma and Merck KGaA Launch Innovative App to Support Bladder Cancer Patients Huma
02-May-2024 Brits spent a record amount on healthcare in 2023 – but by choice or is the NHS failing? London Medical Laboratory